![](https://endpts.com/wp-content/uploads/2024/04/GettyImages-2118338252-scaled.jpg)
Pascal Soriot, AstraZeneca CEO (Yang Guanyu/Xinhua via Getty Images)
AstraZeneca details ‘very ambitious’ strategy for early-stage obesity programs
AstraZeneca plans to develop treatment options for people with different BMIs as part of its “very ambitious” obesity strategy.
AstraZeneca CEO Pascal Soriot on Thursday …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.